US20130131671A1 - Spectroscopic method and system for assessing tissue temperature - Google Patents
Spectroscopic method and system for assessing tissue temperature Download PDFInfo
- Publication number
- US20130131671A1 US20130131671A1 US13/742,107 US201313742107A US2013131671A1 US 20130131671 A1 US20130131671 A1 US 20130131671A1 US 201313742107 A US201313742107 A US 201313742107A US 2013131671 A1 US2013131671 A1 US 2013131671A1
- Authority
- US
- United States
- Prior art keywords
- tissue
- temperature
- determining
- ablation
- water absorption
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/01—Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/1815—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using microwaves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00022—Sensing or detecting at the treatment site
- A61B2017/00057—Light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00022—Sensing or detecting at the treatment site
- A61B2017/00084—Temperature
Definitions
- the present disclosure relates generally to medical devices and, more particularly, to the use of spectroscopy to monitor changes in the temperature of water-bearing tissue.
- tissue ablation uses energy directed at the tissue site of interest to heat the tissue to temperatures that destroy the viability of the individual components of the tissue cells.
- tissue ablation an unwanted portion of a tissue, e.g., fibrous tissue, lesions, or obstructions, may be destroyed.
- Ablation can be achieved by various techniques, including the application of radio frequency energy, microwave energy, lasers, and ultrasound.
- ablation procedures involve ablating tissue that is surrounded by otherwise healthy tissue that a clinician wishes to preserve. Accordingly, better therapeutic outcomes may be achieved through precise application of the ablating energy to the tissue.
- the precision of the ablation may depend in part on the type of energy applied, the skill of the clinician, and the accessibility of the tissue in question.
- ablation may be complex if the target area is moving.
- the cardiac tissue in question is typically in motion, which may affect the volume of tissue ablated.
- assessment of the volume of the tissue necrosis may be difficult.
- controlling the area of the ablation may be easier than controlling the depth of the ablation. Accordingly, the depth of the necrosis may vary from patient to patient.
- FIG. 1 is a graph of the absorption spectra for water for two different temperature points
- FIG. 2 is a graph of estimated mean photon penetration depth plotted against wavelength for a sample of 70% lean water concentration and an emitter-detector spacing of 2.5 mm;
- FIG. 3 is a graph of a simulated absorption spectrum of water for an example tissue sample at 37° C. and an emitter-detector spacing of 2.5 mm;
- FIG. 4 is a graph of a simulated absorption spectrum of water for an example tissue sample at 50-60° C. and an emitter-detector spacing of 2.5 mm;
- FIG. 5 is a graph of a simulated absorption spectrum of water for an example tissue sample at 60-80° C. and an emitter-detector spacing of 2.5 mm;
- FIG. 6 is a block diagram of a system for monitoring tissue temperature according to an embodiment
- FIG. 7 is a side view of an example of a spectroscopic sensor for acquiring information from the tissue according to an embodiment
- FIG. 8 is a top view of an example of a spectroscopic sensor with multiple detectors spaced apart from an emitter for acquiring information from the tissue according to an embodiment
- FIG. 9 is a block diagram of a method of monitoring tissue temperature during ablation.
- a medical monitor may assess changes in spectrophotometric parameters to determine the viability of a probed area of the tissue. Tissue areas with water absorption profiles characteristic of particular temperatures may be determined. Such systems may also be used to determine the viability of the probed tissue, i.e., probed tissues associated with temperatures above a certain threshold may be considered nonviable. As a result, the efficacy of the ablation may be determined.
- the spectroscopic sensors as provided may be used in conjunction with other types of medical procedures that involve changing or monitoring tissue temperature, such as hypothermic or hyperthermic treatments.
- spectroscopic sensing may be used to noninvasively monitor tissue temperature at a number of tissue depths. The temperature information may then be used to determine the scope of the tissue ablation. Generally, ablated tissue cells will have characteristically higher temperatures as a result of the heat of ablation. During ablation, the tissue is heated until the resultant higher temperature of the tissue causes protein denaturation and other effects that lead to necrosis of the tissue. The temperature changes may be monitored by spectroscopically assessing changes in the shape, position and/or magnitude of one or more water absorption peaks of the tissue.
- wavelengths may be chosen that penetrate known depths of the patient's tissue
- temperature information may be collected for relatively fine gradations of tissue depth that are otherwise difficult to obtain.
- Such noninvasive monitoring may provide information about the depth and/or volume of the tissue ablation and may allow clinicians to more precisely determine whether further ablating treatment may be needed.
- clinicians may be able to determine the borders of any ablated tissue in relation to the healthy tissue and may be able to match the borders with previously acquired data (e.g., cardiac images or tumors) to determine if the scope of the ablated tissue corresponds with the size, location and/or shape of, for example, known obstructions or tumors.
- Sensors as provided may be applied to a patient's skin and/or internal organs (e.g., as part of a catheter or other inserted assembly) to monitor multiple absorption peaks of water, for example in the red or near infrared spectrum. While other potential absorbers may make up some percentage of the content of a patient's tissue, many of these absorbers, such as lipid and hemoglobin, do not change their absorption profiles significantly with temperature. For this reason, the absorption of water or other constituents whose absorption, as measured spectroscopically, changes with temperature may provide more information that relates to the tissue temperature.
- FIG. 1 is a graph 10 of successive absorption peaks 12 , 14 , 16 , and 18 (corresponding to peaks centered near approximately 975, 1180, 1450, and 1900, respectively).
- FIG. 2 is a graph 30 of estimated photon penetration depth into tissue plotted against wavelength for light emitted into tissue and detected by a detector spaced approximately 2.5 mm from the emitter.
- the tissue sample is assumed to have 70% lean water concentration, which is approximately the lean water concentration of typical tissue.
- the penetration depth varies with wavelength. Accordingly, a particular wavelength is associated with a particular penetration depth for a particular emitter-detector spacing.
- multiple spectroscopic temperature estimates corresponding to multiple tissue depths may be combined to estimate a thermal gradient that is predictive of the total volume of tissue that has been rendered nonviable by ablation.
- FIGS. 3-5 Simulations of the types of shifts seen at different tissue temperatures are depicted in FIGS. 3-5 , with all simulations assuming a 2.5 mm separation between emitter and detector, with both facing the same direction and embedded in tissue at or near the heating source.
- multi-linear regressions were performed against experimentally determined tissue component spectra of water, protein, and lipid, plus the derivative of water absorption with respect to temperature. These regressions were performed using data over the spectral ranges of 945-1035 nm, 1127-1170 nm, and 1360-1570 nm, corresponding to regions of tissue spectrum where water is the dominant absorber and where water absorption changes significantly with temperature.
- Mean photon penetration depths were determined to be, respectively, 0.94 mm, 0.86 mm, and 0.52 mm for these spectral ranges, and did not differ significantly between these examples. However, in certain embodiments, depending ion the nature and temperature of ablation, a significant decrease in tissue water content may occur after ablation. A decrease in water content may allow deeper penetration for a particular wavelength. Accordingly, the mean photon penetration may increase over the course of the ablation. Such effects may be accounted for in determining the temperature gradient for a particular tissue sample. Similar temperature estimates may be obtained via other methods of comparing tissue spectra to features of tissue component spectra. For example, regressions may be performed between derivatives, or other mathematical functions, of tissue and component spectra.
- Table I shows the resulting temperatures estimated from the multi-linear regressions corresponding to each example and spectral range. As shown, the temperatures increase over the course of the ablation.
- Spectral Range Temp FIG. 1 Temp FIG. 2 Temp FIG. 3 945-1035 nm 36.83° C. 49.45° C. 58.45° C. 1127-1170 nm 37.55° C. 47.33° C. 60.43° C. 1360-1570 nm 37.52° C. 60.64° C. 82.16° C.
- the example shown in FIG. 3 is a graph 40 of absorption at multiple mean photon penetration depths at a plurality of near infrared water absorption peaks.
- the mean photon penetration depths may be estimated by using a graph similar to FIG. 2 of mean photon distribution for a particular emitter-detector spacing.
- tissue Prior to heating, tissue is simulated at 37° C., assuming a tissue composition of 66% water, 24% protein, and 10% lipid. Because this corresponds to a pre-ablation tissue temperature, the temperature at different depths is generally about 37° C., corresponding to normal body temperature, before any heating through ablation occurs.
- FIG. 4 is a graph 50 of a simulation of tissue heating during the course of ablation. At a depth of 0.5 mm, the temperature was simulated to be 60° C., changing linearly to 50° C. at a distance of 1.0 mm. This corresponds with the temperature being highest closer to the ablating source and lower the farther away from the source.
- the tissue is assumed to have dried out during heating to a composition of 58% water, 30% protein, and 12% lipid. As shown, the center of the water absorption peak in the 1350-1600 nm range has shifted toward the shorter wavelengths as a result of temperature change.
- FIG. 5 is a graph 60 of temperatures reached shortly after the completion of an ablating course of energy.
- the temperature was simulated to be 80° C., changing linearly to 60° C. at a distance of 1.0 mm.
- the tissue is assumed to have dried out further due to continued heating, to a composition of 40% water, 42% protein, and 17% lipid.
- the center of the water absorption peak in the 1350-1600 nm range has shifted toward the shorter wavelengths as a result of temperature change. A shifting and narrowing of the water absorption peak in the 1350-1600 nm range may be observed.
- FIG. 6 shows a system 70 that may be used for monitoring temperature in conjunction with an ablation procedure.
- the system 70 includes a spectroscopic sensor 72 with a light emitter 74 and detector 76 that may be of any suitable type.
- the emitter 74 may be a broad spectrum emitter or may be configured to emit light of a limited wavelength range or at select discrete wavelengths.
- the emitter 72 may include a filter wheel for tuning a broad spectrum to a series of particular wavelengths.
- the emitter 74 may be one or more light emitting diodes adapted to transmit one or more wavelengths of light in the red to infrared range, and the detector 76 may be a photodetector configured to receive the emitted light.
- the emitter 74 may be a laser diode or a vertical cavity surface emitting laser (VCSEL).
- the laser diode may be a tunable laser, such that a single diode may be tuned to various wavelengths corresponding to a number of absorption peaks of water.
- the emitter 74 may be associated with an optical fiber for transmitting the emitted light into the tissue.
- the light may be any suitable wavelength corresponding to the wavelengths absorbed by water. For example, wavelengths between about 800 nm, corresponding with far-red visible light, and about 1800 nm, in the near infrared range, may be absorbed by water.
- FIG. 6 shows an ablation device 78 that may be associated with the system 70 .
- ablation device 78 is merely illustrative of a medical device that may be used in conjunction with a spectroscopic sensor 72 for monitoring temperature and other devices may be incorporated into the system 70 if appropriate.
- the ablation device may be a microwave ablation device 78 .
- the sensor 72 is structurally associated (e.g., is disposed on) the ablation device, for example the emitter 74 and the detector 76 are disposed on a catheter, such as a cardiac catheter, or other implantable portion of the device.
- the emitter and detector may be part of a housing or other support structure for the ablation energy source.
- An associated monitor 82 may receive signals, for example from the spectroscopy sensor 72 through a sensor interface (e.g., a sensor port or a wireless interface) and, in embodiments, from the ablation device 78 , to determine if the ablation has generated sufficiently high tissue temperature to destroy the viability of the tissue in the area of interest.
- the monitor 82 may include appropriate processing circuitry for determining temperature parameters, such as a microprocessor 92 , which may be coupled to an internal bus 94 . Also connected to the bus may be a RAM memory 96 and a display 98 .
- a time processing unit (TPU) 100 may provide timing control signals to light drive circuitry 102 , which controls when the emitter 74 is activated, and, if multiple light sources are used, the multiplexed timing for the different light sources. TPU 100 may also control the gating-in of signals from the sensor 72 and amplifier 103 and a switching circuit 104 . These signals are sampled at the proper time, depending at least in part upon which of multiple light sources is activated, if multiple light sources are used.
- the received signal from the sensor 72 may be passed through an amplifier 106 , a low pass filter 108 , and an analog-to-digital converter 110 .
- the digital data may then be stored in a queued serial module (QSM) 112 , for later downloading to RAM 96 as QSM 112 fills up.
- QSM queued serial module
- microprocessor 92 may calculate the microcirculation parameters using various algorithms.
- the microprocessor 92 may calculate tissue temperature. These algorithms may employ certain coefficients, which may be empirically determined, and may correspond to the wavelength of light used. In addition, the algorithms may employ additional correction coefficients. The algorithms and coefficients may be stored in a ROM 116 or other suitable computer-readable storage medium and accessed and operated according to microprocessor 92 instructions. In one embodiment, the correction coefficients may be provided as a lookup table.
- the senor 72 may include certain data storage elements, such as an encoder 120 , that may encode information related to the characteristics of the sensor 72 , including information about the emitter 74 and the detector 76 . The information may be accessed by detector/decoder 122 , located on the monitor 82 . Control inputs 124 may allow an operator to input patient and/or sensor characteristics.
- an encoder 120 may encode information related to the characteristics of the sensor 72 , including information about the emitter 74 and the detector 76 . The information may be accessed by detector/decoder 122 , located on the monitor 82 .
- Control inputs 124 may allow an operator to input patient and/or sensor characteristics.
- the senor 72 may be incorporated into the ablation device 78 or, may, in other embodiments, be a separate device.
- FIGS. 7-8 show examples of configurations for the sensor 72 .
- the emitter 74 is spaced apart from the detector 76 a particular distance that may be stored into the encoder 110 , so that the monitor may perform the analysis of the mean photon penetration associated with a particular emitter-detector spacing.
- the emitter 74 may be capable of emitting light of multiple wavelengths. Depending on the wavelength, the mean photon penetration depth may be shallower, as shown for path 130 , or may be deeper, as shown for path 132 . By collecting data from different depths, a temperature gradient through the tissue may be determined.
- a sensor 72 may also incorporate additional detectors 76 with varied spacing around the emitter 74 . As shown in FIG. 8 , a sensor 72 may incorporate detectors spaced apart different distances (shown as distances d 1 , d 2 , d 3 , and d 4 ) from an emitter 74 . If the distances correspond with characteristic water absorption profiles and mean photon penetration depths, then any change that occurs during an ablation may be correlated to a empirically or mathematically-derived tissue temperature.
- FIG. 9 is a process flow diagram illustrating a method 134 for determining tissue temperature during an ablation procedure in accordance with some embodiments.
- the method may be performed as an automated procedure by a system, such as system 70 .
- certain steps of the method may be performed by a processor, or a processor-based device such as a patient monitor 82 that includes instructions for implementing certain steps of the method 134 .
- the method 134 begins with obtaining a baseline, pre-ablation signal representative of one or more water absorption peaks from detector 76 associated with the sensor 72 (block 136 ).
- the pre-ablation signal may be associated with normal body temperatures.
- the ablation device 78 may be activated and the sensor 72 may collect data during the ablation (block 138 ).
- the sensor 72 may also collect post-ablation data (block 140 ).
- the monitor 82 may perform analysis of the signals from the sensor 72 and calculation of the tissue temperature (block 142 ) based on the signal obtained.
- the tissue temperature may be determined by examining changes in the water absorption peaks over the course of the ablation. If the change in the temperature is indicative of ablation (i.e., nonviability of the tissue), a monitor 82 may determine that a successful ablation has occurred. For example, tissue temperatures in excess of 43° C., 50° C., 60° C., or 80° C. may be indicative of ablation.
- monitoring may include any appropriate visual indication, such as a display of a temperature or temperature versus depth, displayed on the monitor 82 or any appropriate audio indication. For example, an increase of tissue temperature above a predetermined viability threshold or outside of a predetermined range may trigger an alarm or may trigger an indication of ablation. Further, additional indications may include text or other alerts to inform that the ablation was likely successful.
Abstract
According to various embodiments, a medical system and method for determining tissue temperature may include a spectroscopic sensor. The spectroscopic sensors may be configured to provide information about changes in water absorption profiles at one or more absorption peaks. Such sensors may be incorporated into ablation systems for tissue ablation. Temperature information may be used to determine the scope, volume, and/or depth of the ablation.
Description
- This application is a divisional application of U.S. patent application Ser. No. 12/569,721, entitled “Spectroscopic Method and System for Assessing Tissue Temperature,” filed Sep. 29, 2009, the disclosure of which is hereby incorporated by reference in its entirety for all purposes.
- The present disclosure relates generally to medical devices and, more particularly, to the use of spectroscopy to monitor changes in the temperature of water-bearing tissue.
- This section is intended to introduce the reader to aspects of the art that may be related to various aspects of the present disclosure, which are described and/or claimed below. This discussion is believed to be helpful in providing the reader with background information to facilitate a better understanding of the various aspects of the present disclosure. Accordingly, it should be understood that these statements are to be read in this light, and not as admissions of prior art.
- Some forms of patient treatment involve removing unwanted portions of tissue from the patient, for example by surgical resection. However, for tissue areas that may be difficult to access surgically or for very small areas of tissue, tissue ablation may be more appropriate. Tissue ablation uses energy directed at the tissue site of interest to heat the tissue to temperatures that destroy the viability of the individual components of the tissue cells. During tissue ablation, an unwanted portion of a tissue, e.g., fibrous tissue, lesions, or obstructions, may be destroyed. Ablation can be achieved by various techniques, including the application of radio frequency energy, microwave energy, lasers, and ultrasound. Generally, ablation procedures involve ablating tissue that is surrounded by otherwise healthy tissue that a clinician wishes to preserve. Accordingly, better therapeutic outcomes may be achieved through precise application of the ablating energy to the tissue.
- The precision of the ablation may depend in part on the type of energy applied, the skill of the clinician, and the accessibility of the tissue in question. For example, ablation may be complex if the target area is moving. During catheter ablation to correct an abnormal heartbeat, the cardiac tissue in question is typically in motion, which may affect the volume of tissue ablated. Because the ablation may take place internally, as in the case of cardiac ablation, assessment of the volume of the tissue necrosis may be difficult. In addition, depending on the type of ablating energy used, controlling the area of the ablation may be easier than controlling the depth of the ablation. Accordingly, the depth of the necrosis may vary from patient to patient.
- Advantages of the disclosure may become apparent upon reading the following detailed description and upon reference to the drawings in which:
-
FIG. 1 is a graph of the absorption spectra for water for two different temperature points; -
FIG. 2 is a graph of estimated mean photon penetration depth plotted against wavelength for a sample of 70% lean water concentration and an emitter-detector spacing of 2.5 mm; -
FIG. 3 is a graph of a simulated absorption spectrum of water for an example tissue sample at 37° C. and an emitter-detector spacing of 2.5 mm; -
FIG. 4 is a graph of a simulated absorption spectrum of water for an example tissue sample at 50-60° C. and an emitter-detector spacing of 2.5 mm; -
FIG. 5 is a graph of a simulated absorption spectrum of water for an example tissue sample at 60-80° C. and an emitter-detector spacing of 2.5 mm; -
FIG. 6 is a block diagram of a system for monitoring tissue temperature according to an embodiment; -
FIG. 7 is a side view of an example of a spectroscopic sensor for acquiring information from the tissue according to an embodiment; -
FIG. 8 is a top view of an example of a spectroscopic sensor with multiple detectors spaced apart from an emitter for acquiring information from the tissue according to an embodiment; and -
FIG. 9 is a block diagram of a method of monitoring tissue temperature during ablation. - One or more specific embodiments of the present disclosure will be described below. In an effort to provide a concise description of these embodiments, not all features of an actual implementation are described in the specification. It should be appreciated that in the development of any such actual implementation, as in any engineering or design project, numerous implementation-specific decisions must be made to achieve the developers' specific goals, such as compliance with system-related and business-related constraints, which may vary from one implementation to another. Moreover, it should be appreciated that such a development effort might be complex and time consuming, but would nevertheless be a routine undertaking of design, fabrication, and manufacture for those of ordinary skill having the benefit of this disclosure.
- Provided herein are systems, sensors, and methods for spectroscopic monitoring of tissue temperature. When such systems are used in conjunction with a tissue ablation device, a medical monitor may assess changes in spectrophotometric parameters to determine the viability of a probed area of the tissue. Tissue areas with water absorption profiles characteristic of particular temperatures may be determined. Such systems may also be used to determine the viability of the probed tissue, i.e., probed tissues associated with temperatures above a certain threshold may be considered nonviable. As a result, the efficacy of the ablation may be determined. In other embodiments, the spectroscopic sensors as provided may be used in conjunction with other types of medical procedures that involve changing or monitoring tissue temperature, such as hypothermic or hyperthermic treatments.
- Monitoring the necrosis of ablated tissue may be complex, particularly when using techniques that involve ablation of internal tissue. As provided herein, spectroscopic sensing may be used to noninvasively monitor tissue temperature at a number of tissue depths. The temperature information may then be used to determine the scope of the tissue ablation. Generally, ablated tissue cells will have characteristically higher temperatures as a result of the heat of ablation. During ablation, the tissue is heated until the resultant higher temperature of the tissue causes protein denaturation and other effects that lead to necrosis of the tissue. The temperature changes may be monitored by spectroscopically assessing changes in the shape, position and/or magnitude of one or more water absorption peaks of the tissue. Because wavelengths may be chosen that penetrate known depths of the patient's tissue, temperature information may be collected for relatively fine gradations of tissue depth that are otherwise difficult to obtain. Such noninvasive monitoring may provide information about the depth and/or volume of the tissue ablation and may allow clinicians to more precisely determine whether further ablating treatment may be needed. In addition, clinicians may be able to determine the borders of any ablated tissue in relation to the healthy tissue and may be able to match the borders with previously acquired data (e.g., cardiac images or tumors) to determine if the scope of the ablated tissue corresponds with the size, location and/or shape of, for example, known obstructions or tumors.
- Sensors as provided may be applied to a patient's skin and/or internal organs (e.g., as part of a catheter or other inserted assembly) to monitor multiple absorption peaks of water, for example in the red or near infrared spectrum. While other potential absorbers may make up some percentage of the content of a patient's tissue, many of these absorbers, such as lipid and hemoglobin, do not change their absorption profiles significantly with temperature. For this reason, the absorption of water or other constituents whose absorption, as measured spectroscopically, changes with temperature may provide more information that relates to the tissue temperature. Accordingly, by monitoring changes in the water absorption profile that occur with rising temperatures for a single area of tissue (e.g., pre and post-ablation), a change in temperature for the tissue area may be estimated. To account for the variation in light scattering, a change may be measured against a pre-ablation spectrum. In addition, such information may be combined with a measured patient baseline temperature, either local or systemic, to determine the extent of tissue temperature changes. The near-infrared peaks of water shift and narrow with increasing temperature due to increases in hydrogen bonding between water molecules.
FIG. 1 is agraph 10 ofsuccessive absorption peaks data 20, and at 60° C., shown bydata 22, plotted against the depth of tissue penetration. As illustrated, the water at 60° C. is shown to have a different characteristic absorption profile. -
FIG. 2 is agraph 30 of estimated photon penetration depth into tissue plotted against wavelength for light emitted into tissue and detected by a detector spaced approximately 2.5 mm from the emitter. In the depicted simulation, the tissue sample is assumed to have 70% lean water concentration, which is approximately the lean water concentration of typical tissue. As shown, over a portion of the spectrum, the penetration depth varies with wavelength. Accordingly, a particular wavelength is associated with a particular penetration depth for a particular emitter-detector spacing. By using a sensor or a combination of sensors with different emitter-detector spacings as well as different wavelengths, multiple spectroscopic temperature estimates corresponding to multiple tissue depths may be combined to estimate a thermal gradient that is predictive of the total volume of tissue that has been rendered nonviable by ablation. - Simulations of the types of shifts seen at different tissue temperatures are depicted in
FIGS. 3-5 , with all simulations assuming a 2.5 mm separation between emitter and detector, with both facing the same direction and embedded in tissue at or near the heating source. For each exemplary simulated tissue spectrum, multi-linear regressions were performed against experimentally determined tissue component spectra of water, protein, and lipid, plus the derivative of water absorption with respect to temperature. These regressions were performed using data over the spectral ranges of 945-1035 nm, 1127-1170 nm, and 1360-1570 nm, corresponding to regions of tissue spectrum where water is the dominant absorber and where water absorption changes significantly with temperature. Mean photon penetration depths were determined to be, respectively, 0.94 mm, 0.86 mm, and 0.52 mm for these spectral ranges, and did not differ significantly between these examples. However, in certain embodiments, depending ion the nature and temperature of ablation, a significant decrease in tissue water content may occur after ablation. A decrease in water content may allow deeper penetration for a particular wavelength. Accordingly, the mean photon penetration may increase over the course of the ablation. Such effects may be accounted for in determining the temperature gradient for a particular tissue sample. Similar temperature estimates may be obtained via other methods of comparing tissue spectra to features of tissue component spectra. For example, regressions may be performed between derivatives, or other mathematical functions, of tissue and component spectra. - Table I below shows the resulting temperatures estimated from the multi-linear regressions corresponding to each example and spectral range. As shown, the temperatures increase over the course of the ablation.
-
Spectral Range Temp FIG. 1 Temp FIG. 2 Temp FIG. 3 945-1035 nm 36.83° C. 49.45° C. 58.45° C. 1127-1170 nm 37.55° C. 47.33° C. 60.43° C. 1360-1570 nm 37.52° C. 60.64° C. 82.16° C. - The example shown in
FIG. 3 is agraph 40 of absorption at multiple mean photon penetration depths at a plurality of near infrared water absorption peaks. The mean photon penetration depths may be estimated by using a graph similar toFIG. 2 of mean photon distribution for a particular emitter-detector spacing. Prior to heating, tissue is simulated at 37° C., assuming a tissue composition of 66% water, 24% protein, and 10% lipid. Because this corresponds to a pre-ablation tissue temperature, the temperature at different depths is generally about 37° C., corresponding to normal body temperature, before any heating through ablation occurs. - After ablation begins, the temperature of the tissue starts to rise and the water absorption profile begins to show characteristic shifting.
FIG. 4 is agraph 50 of a simulation of tissue heating during the course of ablation. At a depth of 0.5 mm, the temperature was simulated to be 60° C., changing linearly to 50° C. at a distance of 1.0 mm. This corresponds with the temperature being highest closer to the ablating source and lower the farther away from the source. The tissue is assumed to have dried out during heating to a composition of 58% water, 30% protein, and 12% lipid. As shown, the center of the water absorption peak in the 1350-1600 nm range has shifted toward the shorter wavelengths as a result of temperature change. - After the ablation is completed, the temperatures have reached their highest point in the tissue and the affected region is rendered nonviable.
FIG. 5 is agraph 60 of temperatures reached shortly after the completion of an ablating course of energy. At a depth of 0.5 mm, the temperature was simulated to be 80° C., changing linearly to 60° C. at a distance of 1.0 mm. The tissue is assumed to have dried out further due to continued heating, to a composition of 40% water, 42% protein, and 17% lipid. As shown, the center of the water absorption peak in the 1350-1600 nm range has shifted toward the shorter wavelengths as a result of temperature change. A shifting and narrowing of the water absorption peak in the 1350-1600 nm range may be observed. -
FIG. 6 shows asystem 70 that may be used for monitoring temperature in conjunction with an ablation procedure. Thesystem 70 includes aspectroscopic sensor 72 with alight emitter 74 anddetector 76 that may be of any suitable type. Theemitter 74 may be a broad spectrum emitter or may be configured to emit light of a limited wavelength range or at select discrete wavelengths. In one embodiment, theemitter 72 may include a filter wheel for tuning a broad spectrum to a series of particular wavelengths. Theemitter 74 may be one or more light emitting diodes adapted to transmit one or more wavelengths of light in the red to infrared range, and thedetector 76 may be a photodetector configured to receive the emitted light. In specific embodiments, theemitter 74 may be a laser diode or a vertical cavity surface emitting laser (VCSEL). The laser diode may be a tunable laser, such that a single diode may be tuned to various wavelengths corresponding to a number of absorption peaks of water. Depending on the particular arrangement of thesensor 72, theemitter 74 may be associated with an optical fiber for transmitting the emitted light into the tissue. The light may be any suitable wavelength corresponding to the wavelengths absorbed by water. For example, wavelengths between about 800 nm, corresponding with far-red visible light, and about 1800 nm, in the near infrared range, may be absorbed by water. - By way of example,
FIG. 6 shows anablation device 78 that may be associated with thesystem 70. However, it should be understood thatablation device 78 is merely illustrative of a medical device that may be used in conjunction with aspectroscopic sensor 72 for monitoring temperature and other devices may be incorporated into thesystem 70 if appropriate. In certain embodiments, the ablation device may be amicrowave ablation device 78. In one embodiment, thesensor 72 is structurally associated (e.g., is disposed on) the ablation device, for example theemitter 74 and thedetector 76 are disposed on a catheter, such as a cardiac catheter, or other implantable portion of the device. In embodiments in which the ablation takes place on the surface of the skin, the emitter and detector may be part of a housing or other support structure for the ablation energy source. - An associated
monitor 82 may receive signals, for example from thespectroscopy sensor 72 through a sensor interface (e.g., a sensor port or a wireless interface) and, in embodiments, from theablation device 78, to determine if the ablation has generated sufficiently high tissue temperature to destroy the viability of the tissue in the area of interest. Themonitor 82 may include appropriate processing circuitry for determining temperature parameters, such as amicroprocessor 92, which may be coupled to aninternal bus 94. Also connected to the bus may be aRAM memory 96 and adisplay 98. A time processing unit (TPU) 100 may provide timing control signals tolight drive circuitry 102, which controls when theemitter 74 is activated, and, if multiple light sources are used, the multiplexed timing for the different light sources.TPU 100 may also control the gating-in of signals from thesensor 72 andamplifier 103 and aswitching circuit 104. These signals are sampled at the proper time, depending at least in part upon which of multiple light sources is activated, if multiple light sources are used. The received signal from thesensor 72 may be passed through anamplifier 106, alow pass filter 108, and an analog-to-digital converter 110. The digital data may then be stored in a queued serial module (QSM) 112, for later downloading to RAM 96 asQSM 112 fills up. - In an embodiment, based at least in part upon the received signals corresponding to the water absorption peaks received by
detector 76 of thesensor 72,microprocessor 92 may calculate the microcirculation parameters using various algorithms. In addition, themicroprocessor 92 may calculate tissue temperature. These algorithms may employ certain coefficients, which may be empirically determined, and may correspond to the wavelength of light used. In addition, the algorithms may employ additional correction coefficients. The algorithms and coefficients may be stored in aROM 116 or other suitable computer-readable storage medium and accessed and operated according tomicroprocessor 92 instructions. In one embodiment, the correction coefficients may be provided as a lookup table. In addition, thesensor 72 may include certain data storage elements, such as anencoder 120, that may encode information related to the characteristics of thesensor 72, including information about theemitter 74 and thedetector 76. The information may be accessed by detector/decoder 122, located on themonitor 82.Control inputs 124 may allow an operator to input patient and/or sensor characteristics. - As noted, the
sensor 72 may be incorporated into theablation device 78 or, may, in other embodiments, be a separate device.FIGS. 7-8 show examples of configurations for thesensor 72. InFIG. 7 , theemitter 74 is spaced apart from the detector 76 a particular distance that may be stored into theencoder 110, so that the monitor may perform the analysis of the mean photon penetration associated with a particular emitter-detector spacing. Theemitter 74 may be capable of emitting light of multiple wavelengths. Depending on the wavelength, the mean photon penetration depth may be shallower, as shown for path 130, or may be deeper, as shown for path 132. By collecting data from different depths, a temperature gradient through the tissue may be determined. - In addition to using different wavelengths to acquire data at different depths, a
sensor 72 may also incorporateadditional detectors 76 with varied spacing around theemitter 74. As shown inFIG. 8 , asensor 72 may incorporate detectors spaced apart different distances (shown as distances d1, d2, d3, and d4) from anemitter 74. If the distances correspond with characteristic water absorption profiles and mean photon penetration depths, then any change that occurs during an ablation may be correlated to a empirically or mathematically-derived tissue temperature. -
FIG. 9 is a process flow diagram illustrating amethod 134 for determining tissue temperature during an ablation procedure in accordance with some embodiments. The method may be performed as an automated procedure by a system, such assystem 70. In addition, certain steps of the method may be performed by a processor, or a processor-based device such as apatient monitor 82 that includes instructions for implementing certain steps of themethod 134. According to an embodiment, themethod 134 begins with obtaining a baseline, pre-ablation signal representative of one or more water absorption peaks fromdetector 76 associated with the sensor 72 (block 136). The pre-ablation signal may be associated with normal body temperatures. Theablation device 78 may be activated and thesensor 72 may collect data during the ablation (block 138). Thesensor 72 may also collect post-ablation data (block 140). Themonitor 82 may perform analysis of the signals from thesensor 72 and calculation of the tissue temperature (block 142) based on the signal obtained. - For example, in one embodiment, the tissue temperature may be determined by examining changes in the water absorption peaks over the course of the ablation. If the change in the temperature is indicative of ablation (i.e., nonviability of the tissue), a
monitor 82 may determine that a successful ablation has occurred. For example, tissue temperatures in excess of 43° C., 50° C., 60° C., or 80° C. may be indicative of ablation. In addition, such monitoring may include any appropriate visual indication, such as a display of a temperature or temperature versus depth, displayed on themonitor 82 or any appropriate audio indication. For example, an increase of tissue temperature above a predetermined viability threshold or outside of a predetermined range may trigger an alarm or may trigger an indication of ablation. Further, additional indications may include text or other alerts to inform that the ablation was likely successful. - While the invention may be susceptible to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and will be described in detail herein. However, it should be understood that the invention is not intended to be limited to the particular forms disclosed. Rather, the invention is to cover all modifications, equivalents and alternatives falling within the spirit and scope of the invention as defined by the following appended claims.
Claims (20)
1. A method, comprising:
using a processor:
receiving a signal from a spectroscopic sensor, wherein a tissue temperature of a patient may be generally determined from the signal;
determining the tissue temperature based at least in part on the signal; and
determining whether the tissue temperature exceeds a viability threshold.
2. The method of claim 1 , wherein the method is performed prior to an ablation being performed on the tissue.
3. The method of claim 1 , wherein the method is performed during an ablation being performed on the tissue.
4. The method of claim 1 , wherein determining the tissue temperature comprises determining a change in a magnitude, shape, or position of at least one water absorption peak.
5. The method of claim 4 , wherein determining the tissue temperature comprises correlating the change to a tissue temperature associated with the change.
6. The method of claim 1 , wherein the viability threshold is greater than about 43° C.
7. The method of claim 1 , wherein determining the tissue temperature comprises determining the temperature at more than one depth in the tissue.
8. The method of claim 1 , wherein the determining the tissue temperature comprises determining a temperature gradient in the tissue.
9. The method of claim 1 , comprising providing a user-perceivable indication of the tissue temperature when the tissue temperature exceeds the viability threshold.
10. A method, comprising:
receiving spectrophotometric data associated with a mean photon penetration depth in a tissue of a patient from a spectrophotometric sensor; and
determining one or more temperatures of the tissue associated with the mean photon penetration depth based at least in part upon the spectrophotometric data.
11. The method of claim 10 , comprising displaying an indication related to the one or more tissue temperatures.
12. The method of claim 10 , wherein determining the one or more tissue temperatures comprising determining a change in a magnitude, position, or shape of a water absorption peak.
13. The method of claim 12 , wherein determining the one or more tissue temperatures comprises correlating the change in the magnitude, position, or shape of the water absorption peak to a tissue temperature associated with the change in the magnitude, position, or shape of the water absorption peak, respectively.
14. The method of claim 10 , comprising:
activating an energy source configured to direct ablating energy into the tissue of the patient; and
determining whether the tissue temperature is associated with heat from the ablating energy.
15. The method of claim 14 , comprising assessing a scope of tissue ablation based at least in part upon the tissue temperature.
16. The method of claim 15 , wherein assessing the scope of tissue ablation comprises determining a viability of the tissue or determining a volume of ablated tissue.
17. A method, comprising:
measuring one or more water absorption peaks in a tissue of a patient using a spectrophotometric sensor prior to an ablation procedure being performed on the tissue;
measuring the one or more water absorption peaks in the tissue using the spectrophotometric sensor during the ablation procedure; and
determining a temperature of the tissue based at least in part upon the measurements acquired prior to and during the ablation procedure.
18. The method of claim 17 , comprising:
measuring the one or more water absorption peaks in the tissue using the spectrophotometric sensor subsequent to the ablation procedure; and
determining the temperature of the tissue based at least in part upon the measurement acquired subsequent to the ablation procedure.
19. The method of claim 17 , wherein determining the temperature of the tissue comprises determining a change in a magnitude, position, or shape of the one or more water absorption peaks.
20. The method of claim 17 , comprising:
receiving information related to the tissue ablation procedure; and
assessing the tissue ablation based at least in part upon the tissue temperature.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/742,107 US20130131671A1 (en) | 2009-09-29 | 2013-01-15 | Spectroscopic method and system for assessing tissue temperature |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/569,721 US8376955B2 (en) | 2009-09-29 | 2009-09-29 | Spectroscopic method and system for assessing tissue temperature |
US13/742,107 US20130131671A1 (en) | 2009-09-29 | 2013-01-15 | Spectroscopic method and system for assessing tissue temperature |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/569,721 Division US8376955B2 (en) | 2009-09-29 | 2009-09-29 | Spectroscopic method and system for assessing tissue temperature |
Publications (1)
Publication Number | Publication Date |
---|---|
US20130131671A1 true US20130131671A1 (en) | 2013-05-23 |
Family
ID=43781119
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/569,721 Active 2031-05-10 US8376955B2 (en) | 2009-09-29 | 2009-09-29 | Spectroscopic method and system for assessing tissue temperature |
US13/742,107 Abandoned US20130131671A1 (en) | 2009-09-29 | 2013-01-15 | Spectroscopic method and system for assessing tissue temperature |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/569,721 Active 2031-05-10 US8376955B2 (en) | 2009-09-29 | 2009-09-29 | Spectroscopic method and system for assessing tissue temperature |
Country Status (1)
Country | Link |
---|---|
US (2) | US8376955B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8855153B2 (en) * | 2012-11-08 | 2014-10-07 | Hon Hai Precision Industry Co., Ltd. | Laser machining control system through feedback |
DE102019121366A1 (en) * | 2019-08-07 | 2021-02-11 | Aesculap Ag | Apparatus and method for measuring tissue temperature |
US11648047B2 (en) | 2017-10-06 | 2023-05-16 | Vive Scientific, Llc | System and method to treat obstructive sleep apnea |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160081555A1 (en) * | 2014-09-18 | 2016-03-24 | Biosense Webster (Israel) Ltd. | Multi-range optical sensing |
JP2023505865A (en) | 2019-12-11 | 2023-02-13 | ロックリー フォトニクス リミテッド | light detection module |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4246784A (en) * | 1979-06-01 | 1981-01-27 | Theodore Bowen | Passive remote temperature sensor system |
US6355030B1 (en) * | 1998-09-25 | 2002-03-12 | Cardiothoracic Systems, Inc. | Instruments and methods employing thermal energy for the repair and replacement of cardiac valves |
US20020035341A1 (en) * | 1995-08-09 | 2002-03-21 | Rio Grande Medical Technologies, Inc. | Method and apparatus for non-invasive blood analyte measurement with fluid compartment equilibration |
US6615071B1 (en) * | 1995-09-20 | 2003-09-02 | Board Of Regents, The University Of Texas System | Method and apparatus for detecting vulnerable atherosclerotic plaque |
US20030236443A1 (en) * | 2002-04-19 | 2003-12-25 | Cespedes Eduardo Ignacio | Methods and apparatus for the identification and stabilization of vulnerable plaque |
US6763261B2 (en) * | 1995-09-20 | 2004-07-13 | Board Of Regents, The University Of Texas System | Method and apparatus for detecting vulnerable atherosclerotic plaque |
US20040167382A1 (en) * | 1995-08-09 | 2004-08-26 | Gardner Craig M. | Non-invasive determination of direction and rate of change of an analyte |
US20090005771A1 (en) * | 2007-06-28 | 2009-01-01 | Chad Allen Lieber | Optical Pyrometric Catheter for Tissue Temperature Monitoring During Cardiac Ablation |
US20090143774A1 (en) * | 2006-05-30 | 2009-06-04 | Koninklijke Philips Electronics N.V. | Apparatus for depth-resolved measurements of properties of tissue |
US20100069782A1 (en) * | 2007-06-15 | 2010-03-18 | University Of Tennessee Research Foundation | Passive Microwave Assessment of Human Body Core to Surface Temperature Gradients and Basal Metabolic Rate |
Family Cites Families (221)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3638640A (en) | 1967-11-01 | 1972-02-01 | Robert F Shaw | Oximeter and method for in vivo determination of oxygen saturation in blood using three or more different wavelengths |
US3926177A (en) | 1972-09-11 | 1975-12-16 | Cavitron Corp | Activity and respiration monitor |
US3884219A (en) | 1973-04-02 | 1975-05-20 | Medical Monitor Systems | System for determining temperature and respiration rate |
US4028139A (en) | 1975-12-04 | 1977-06-07 | Texaco Inc. | Methods and multiple thermocouple support assembly |
US4938218A (en) | 1983-08-30 | 1990-07-03 | Nellcor Incorporated | Perinatal pulse oximetry sensor |
US4714341A (en) | 1984-02-23 | 1987-12-22 | Minolta Camera Kabushiki Kaisha | Multi-wavelength oximeter having a means for disregarding a poor signal |
US4911167A (en) | 1985-06-07 | 1990-03-27 | Nellcor Incorporated | Method and apparatus for detecting optical pulses |
US4936679A (en) | 1985-11-12 | 1990-06-26 | Becton, Dickinson And Company | Optical fiber transducer driving and measuring circuit and method for using same |
US4913150A (en) | 1986-08-18 | 1990-04-03 | Physio-Control Corporation | Method and apparatus for the automatic calibration of signals employed in oximetry |
US4805623A (en) | 1987-09-04 | 1989-02-21 | Vander Corporation | Spectrophotometric method for quantitatively determining the concentration of a dilute component in a light- or other radiation-scattering environment |
US4807631A (en) | 1987-10-09 | 1989-02-28 | Critikon, Inc. | Pulse oximetry system |
EP0315040B1 (en) | 1987-11-02 | 1993-01-27 | Sumitomo Electric Industries Limited | Bio-photosensor |
IL86759A (en) | 1988-06-16 | 1992-09-06 | Dror Nedivi | Medical monitoring system |
JPH0288041A (en) | 1988-09-24 | 1990-03-28 | Misawahoomu Sogo Kenkyusho:Kk | Finger tip pulse wave sensor |
US5873821A (en) | 1992-05-18 | 1999-02-23 | Non-Invasive Technology, Inc. | Lateralization spectrophotometer |
US4972331A (en) | 1989-02-06 | 1990-11-20 | Nim, Inc. | Phase modulated spectrophotometry |
CA1331483C (en) | 1988-11-02 | 1994-08-16 | Britton Chance | User-wearable hemoglobinometer for measuring the metabolic condition of a subject |
US5122974A (en) | 1989-02-06 | 1992-06-16 | Nim, Inc. | Phase modulated spectrophotometry |
US5564417A (en) | 1991-01-24 | 1996-10-15 | Non-Invasive Technology, Inc. | Pathlength corrected oximeter and the like |
EP0374668A3 (en) | 1988-12-16 | 1992-02-05 | A.W. Faber - Castell GmbH & Co. | Fluorescent marking fluid |
US5553614A (en) | 1988-12-21 | 1996-09-10 | Non-Invasive Technology, Inc. | Examination of biological tissue using frequency domain spectroscopy |
US5119815A (en) | 1988-12-21 | 1992-06-09 | Nim, Incorporated | Apparatus for determining the concentration of a tissue pigment of known absorbance, in vivo, using the decay characteristics of scintered electromagnetic radiation |
US5028787A (en) | 1989-01-19 | 1991-07-02 | Futrex, Inc. | Non-invasive measurement of blood glucose |
US6708048B1 (en) | 1989-02-06 | 2004-03-16 | Non-Invasive Technology, Inc. | Phase modulation spectrophotometric apparatus |
US6183414B1 (en) | 1999-04-26 | 2001-02-06 | Michael S. Wysor | Technique for restoring plasticity to tissues of a male or female organ |
US5483646A (en) | 1989-09-29 | 1996-01-09 | Kabushiki Kaisha Toshiba | Memory access control method and system for realizing the same |
US5190038A (en) | 1989-11-01 | 1993-03-02 | Novametrix Medical Systems, Inc. | Pulse oximeter with improved accuracy and response time |
DE3938759A1 (en) | 1989-11-23 | 1991-05-29 | Philips Patentverwaltung | NON-INVASIVE OXIMETER ARRANGEMENT |
US6246894B1 (en) | 1993-02-01 | 2001-06-12 | In-Line Diagnostics Corporation | System and method for measuring blood urea nitrogen, blood osmolarity, plasma free hemoglobin and tissue water content |
US5372136A (en) | 1990-10-06 | 1994-12-13 | Noninvasive Medical Technology Corporation | System and method for noninvasive hematocrit monitoring |
US6681128B2 (en) | 1990-10-06 | 2004-01-20 | Hema Metrics, Inc. | System for noninvasive hematocrit monitoring |
US6266546B1 (en) | 1990-10-06 | 2001-07-24 | In-Line Diagnostics Corporation | System for noninvasive hematocrit monitoring |
WO1992015955A1 (en) | 1991-03-07 | 1992-09-17 | Vital Signals, Inc. | Signal processing apparatus and method |
US6580086B1 (en) | 1999-08-26 | 2003-06-17 | Masimo Corporation | Shielded optical probe and method |
US5995855A (en) | 1998-02-11 | 1999-11-30 | Masimo Corporation | Pulse oximetry sensor adapter |
US5638818A (en) | 1991-03-21 | 1997-06-17 | Masimo Corporation | Low noise optical probe |
DE4138702A1 (en) | 1991-03-22 | 1992-09-24 | Madaus Medizin Elektronik | METHOD AND DEVICE FOR THE DIAGNOSIS AND QUANTITATIVE ANALYSIS OF APNOE AND FOR THE SIMULTANEOUS DETERMINATION OF OTHER DISEASES |
US6549795B1 (en) | 1991-05-16 | 2003-04-15 | Non-Invasive Technology, Inc. | Spectrophotometer for tissue examination |
US5246003A (en) | 1991-08-28 | 1993-09-21 | Nellcor Incorporated | Disposable pulse oximeter sensor |
US5247931A (en) | 1991-09-16 | 1993-09-28 | Mine Safety Appliances Company | Diagnostic sensor clasp utilizing a slot, pivot and spring hinge mechanism |
DE59209492D1 (en) | 1992-01-25 | 1998-10-15 | Alsthom Cge Alcatel | Procedures to facilitate the operation of end devices in telecommunications systems |
US5385143A (en) | 1992-02-06 | 1995-01-31 | Nihon Kohden Corporation | Apparatus for measuring predetermined data of living tissue |
US5297548A (en) | 1992-02-07 | 1994-03-29 | Ohmeda Inc. | Arterial blood monitoring probe |
JP3249517B2 (en) | 1992-02-28 | 2002-01-21 | キャデル、テオドール・イー | Non-invasive device and method for determining the concentration of various components of blood or tissue |
US5263244A (en) | 1992-04-17 | 1993-11-23 | Gould Inc. | Method of making a flexible printed circuit sensor assembly for detecting optical pulses |
EP0572684B1 (en) | 1992-05-15 | 1996-07-03 | Hewlett-Packard GmbH | Medical sensor |
US6785568B2 (en) | 1992-05-18 | 2004-08-31 | Non-Invasive Technology Inc. | Transcranial examination of the brain |
US5355880A (en) | 1992-07-06 | 1994-10-18 | Sandia Corporation | Reliable noninvasive measurement of blood gases |
US5680857A (en) | 1992-08-28 | 1997-10-28 | Spacelabs Medical, Inc. | Alignment guide system for transmissive pulse oximetry sensors |
EP0615723A1 (en) | 1993-03-04 | 1994-09-21 | Hamamatsu Photonics K.K. | Method and apparatus for measuring blood flow |
EP1491135A3 (en) | 1993-04-12 | 2005-09-07 | Hema Metrics, Inc. | Method and apparatus for monitoring blood constituents |
US6915806B2 (en) * | 1993-05-10 | 2005-07-12 | Arthrocare Corporation | Method for harvesting graft vessel |
CA2155932A1 (en) | 1993-12-14 | 1995-06-22 | Tadakazu Yamauchi | Medical measuring apparatus |
US5645059A (en) | 1993-12-17 | 1997-07-08 | Nellcor Incorporated | Medical sensor with modulated encoding scheme |
JP3238813B2 (en) | 1993-12-20 | 2001-12-17 | テルモ株式会社 | Pulse oximeter |
JP3464697B2 (en) | 1993-12-21 | 2003-11-10 | 興和株式会社 | Oxygen saturation meter |
US5995859A (en) | 1994-02-14 | 1999-11-30 | Nihon Kohden Corporation | Method and apparatus for accurately measuring the saturated oxygen in arterial blood by substantially eliminating noise from the measurement signal |
DE4423597C1 (en) | 1994-07-06 | 1995-08-10 | Hewlett Packard Gmbh | Pulsoximetric ear sensor |
US5662643A (en) * | 1994-09-28 | 1997-09-02 | Abiomed R & D, Inc. | Laser welding system |
DE4439080B4 (en) | 1994-11-02 | 2004-06-03 | Ganshorn Medizin Electronic Gmbh | Whole-body plethysmograph |
US6957094B2 (en) | 1994-12-02 | 2005-10-18 | Non-Invasive Technology, Inc. | Examination of scattering properties of biological tissue |
US5692503A (en) | 1995-03-10 | 1997-12-02 | Kuenstner; J. Todd | Method for noninvasive (in-vivo) total hemoglobin, oxyhemogolobin, deoxyhemoglobin, carboxyhemoglobin and methemoglobin concentration determination |
US5682898A (en) | 1995-04-19 | 1997-11-04 | Colin Corporation | Respiration rate measuring apparatus |
US7035697B1 (en) | 1995-05-30 | 2006-04-25 | Roy-G-Biv Corporation | Access control systems and methods for motion control |
US5638816A (en) | 1995-06-07 | 1997-06-17 | Masimo Corporation | Active pulse blood constituent monitoring |
US5758644A (en) | 1995-06-07 | 1998-06-02 | Masimo Corporation | Manual and automatic probe calibration |
US5645060A (en) | 1995-06-14 | 1997-07-08 | Nellcor Puritan Bennett Incorporated | Method and apparatus for removing artifact and noise from pulse oximetry |
US5995856A (en) | 1995-11-22 | 1999-11-30 | Nellcor, Incorporated | Non-contact optical monitoring of physiological parameters |
SE9600322L (en) | 1996-01-30 | 1997-07-31 | Hoek Instr Ab | Sensor for pulse oximetry with fiber optic signal transmission |
US6309352B1 (en) | 1996-01-31 | 2001-10-30 | Board Of Regents, The University Of Texas System | Real time optoacoustic monitoring of changes in tissue properties |
US6405069B1 (en) | 1996-01-31 | 2002-06-11 | Board Of Regents, The University Of Texas System | Time-resolved optoacoustic method and system for noninvasive monitoring of glucose |
DE59704665D1 (en) | 1996-04-01 | 2001-10-25 | Linde Medical Sensors Ag Basel | DETECTION OF INTERFERENCE SIGNALS IN PULSOXYMETRIC MEASUREMENT |
US5842981A (en) | 1996-07-17 | 1998-12-01 | Criticare Systems, Inc. | Direct to digital oximeter |
US6163715A (en) | 1996-07-17 | 2000-12-19 | Criticare Systems, Inc. | Direct to digital oximeter and method for calculating oxygenation levels |
US6120460A (en) | 1996-09-04 | 2000-09-19 | Abreu; Marcio Marc | Method and apparatus for signal acquisition, processing and transmission for evaluation of bodily functions |
US6544193B2 (en) | 1996-09-04 | 2003-04-08 | Marcio Marc Abreu | Noninvasive measurement of chemical substances |
US5830139A (en) | 1996-09-04 | 1998-11-03 | Abreu; Marcio M. | Tonometer system for measuring intraocular pressure by applanation and/or indentation |
US5871442A (en) | 1996-09-10 | 1999-02-16 | International Diagnostics Technologies, Inc. | Photonic molecular probe |
US6081742A (en) | 1996-09-10 | 2000-06-27 | Seiko Epson Corporation | Organism state measuring device and relaxation instructing device |
US5830136A (en) | 1996-10-31 | 1998-11-03 | Nellcor Puritan Bennett Incorporated | Gel pad optical sensor |
US6487439B1 (en) | 1997-03-17 | 2002-11-26 | Victor N. Skladnev | Glove-mounted hybrid probe for tissue type recognition |
AUPO676397A0 (en) | 1997-05-13 | 1997-06-05 | Dunlop, Colin | Method and apparatus for monitoring haemodynamic function |
CA2303803A1 (en) | 1997-06-17 | 1998-12-23 | Respironics, Inc. | Fetal oximetry system and sensor |
AU7934498A (en) | 1997-06-27 | 1999-01-19 | Toa Medical Electronics Co., Ltd. | Living body inspecting apparatus and noninvasive blood analyzer using the same |
FI973454A (en) | 1997-08-22 | 1999-02-23 | Instrumentarium Oy | A resilient device in a measuring sensor for observing the properties of living tissue |
DE69700384T2 (en) | 1997-12-22 | 1999-11-25 | Hewlett Packard Co | Telemetry system, in particular for medical purposes |
JP3567319B2 (en) | 1997-12-26 | 2004-09-22 | 日本光電工業株式会社 | Probe for pulse oximeter |
DE69940053D1 (en) | 1998-02-05 | 2009-01-22 | Hema Metrics Inc | METHOD AND DEVICE FOR NON-INVASIVE OBSERVATION OF BLOOD COMPONENTS |
JP3576851B2 (en) | 1998-03-23 | 2004-10-13 | キヤノン株式会社 | Liquid crystal display, video camera |
US6526298B1 (en) * | 1998-05-18 | 2003-02-25 | Abbott Laboratories | Method for the non-invasive determination of analytes in a selected volume of tissue |
US6662030B2 (en) | 1998-05-18 | 2003-12-09 | Abbott Laboratories | Non-invasive sensor having controllable temperature feature |
US7043287B1 (en) * | 1998-05-18 | 2006-05-09 | Abbott Laboratories | Method for modulating light penetration depth in tissue and diagnostic applications using same |
DE19823947A1 (en) * | 1998-05-28 | 1999-12-02 | Baasel Carl Lasertech | Method and device for superficial heating of tissue |
IL124787A0 (en) | 1998-06-07 | 1999-01-26 | Itamar Medical C M 1997 Ltd | Pressure applicator devices particularly useful for non-invasive detection of medical conditions |
US5920263A (en) | 1998-06-11 | 1999-07-06 | Ohmeda, Inc. | De-escalation of alarm priorities in medical devices |
US6842635B1 (en) | 1998-08-13 | 2005-01-11 | Edwards Lifesciences Llc | Optical device |
JP2000083933A (en) | 1998-07-17 | 2000-03-28 | Nippon Koden Corp | Instrument for measuring concentration of light absorptive material in vital tissue |
US6671526B1 (en) | 1998-07-17 | 2003-12-30 | Nihon Kohden Corporation | Probe and apparatus for determining concentration of light-absorbing materials in living tissue |
US6949081B1 (en) | 1998-08-26 | 2005-09-27 | Non-Invasive Technology, Inc. | Sensing and interactive drug delivery |
US6117075A (en) | 1998-09-21 | 2000-09-12 | Meduck Ltd. | Depth of anesthesia monitor |
US6064898A (en) | 1998-09-21 | 2000-05-16 | Essential Medical Devices | Non-invasive blood component analyzer |
US6721980B1 (en) | 1998-10-28 | 2004-04-20 | Hill-Fom Services, Inc. | Force optimization surface apparatus and method |
US6606511B1 (en) | 1999-01-07 | 2003-08-12 | Masimo Corporation | Pulse oximetry pulse indicator |
US6684090B2 (en) | 1999-01-07 | 2004-01-27 | Masimo Corporation | Pulse oximetry data confidence indicator |
US6658276B2 (en) | 1999-01-25 | 2003-12-02 | Masimo Corporation | Pulse oximeter user interface |
US6438399B1 (en) | 1999-02-16 | 2002-08-20 | The Children's Hospital Of Philadelphia | Multi-wavelength frequency domain near-infrared cerebral oximeter |
US6360114B1 (en) | 1999-03-25 | 2002-03-19 | Masimo Corporation | Pulse oximeter probe-off detector |
US6675029B2 (en) | 1999-07-22 | 2004-01-06 | Sensys Medical, Inc. | Apparatus and method for quantification of tissue hydration using diffuse reflectance spectroscopy |
US7904139B2 (en) | 1999-08-26 | 2011-03-08 | Non-Invasive Technology Inc. | Optical examination of biological tissue using non-contact irradiation and detection |
AU778361B2 (en) | 1999-10-07 | 2004-12-02 | La Mont, Llc | Physiological signal monitoring apparatus and method |
US6618042B1 (en) | 1999-10-28 | 2003-09-09 | Gateway, Inc. | Display brightness control method and apparatus for conserving battery power |
JP2001149349A (en) | 1999-11-26 | 2001-06-05 | Nippon Koden Corp | Sensor for living body |
US6415236B2 (en) | 1999-11-30 | 2002-07-02 | Nihon Kohden Corporation | Apparatus for determining concentrations of hemoglobins |
US6622095B2 (en) | 1999-11-30 | 2003-09-16 | Nihon Kohden Corporation | Apparatus for determining concentrations of hemoglobins |
US6711424B1 (en) | 1999-12-22 | 2004-03-23 | Orsense Ltd. | Method of optical measurement for determing various parameters of the patient's blood |
US6419671B1 (en) | 1999-12-23 | 2002-07-16 | Visx, Incorporated | Optical feedback system for vision correction |
US6594513B1 (en) | 2000-01-12 | 2003-07-15 | Paul D. Jobsis | Method and apparatus for determining oxygen saturation of blood in body organs |
IL135077A0 (en) | 2000-03-15 | 2001-05-20 | Orsense Ltd | A probe for use in non-invasive measurements of blood related parameters |
ES2392818T3 (en) | 2000-04-17 | 2012-12-14 | Nellcor Puritan Bennett Llc | Pulse oximeter sensor with section function |
US6748259B1 (en) | 2000-06-15 | 2004-06-08 | Spectros Corporation | Optical imaging of induced signals in vivo under ambient light conditions |
US6855112B2 (en) | 2000-07-14 | 2005-02-15 | The University Of Hong Kong | Method of and system for health treatment |
US6889153B2 (en) | 2001-08-09 | 2005-05-03 | Thomas Dietiker | System and method for a self-calibrating non-invasive sensor |
US6487428B1 (en) | 2000-08-31 | 2002-11-26 | Trustees Of The University Of Pennsylvania | Extravasation detection apparatus and method based on optical sensing |
IL138683A0 (en) | 2000-09-25 | 2001-10-31 | Vital Medical Ltd | Apparatus and method for monitoring tissue vitality parameters |
IL138884A (en) | 2000-10-05 | 2006-07-05 | Conmed Corp | Pulse oximeter and a method of its operation |
US6466809B1 (en) | 2000-11-02 | 2002-10-15 | Datex-Ohmeda, Inc. | Oximeter sensor having laminated housing with flat patient interface surface |
US6501974B2 (en) | 2001-01-22 | 2002-12-31 | Datex-Ohmeda, Inc. | Compensation of human variability in pulse oximetry |
US6606509B2 (en) | 2001-03-16 | 2003-08-12 | Nellcor Puritan Bennett Incorporated | Method and apparatus for improving the accuracy of noninvasive hematocrit measurements |
US7239902B2 (en) | 2001-03-16 | 2007-07-03 | Nellor Puritan Bennett Incorporated | Device and method for monitoring body fluid and electrolyte disorders |
US6591122B2 (en) | 2001-03-16 | 2003-07-08 | Nellcor Puritan Bennett Incorporated | Device and method for monitoring body fluid and electrolyte disorders |
US6898451B2 (en) | 2001-03-21 | 2005-05-24 | Minformed, L.L.C. | Non-invasive blood analyte measuring system and method utilizing optical absorption |
US7083593B2 (en) | 2001-04-18 | 2006-08-01 | Advanced Bionics Corporation | Programmable implantable pump with accessory reservoirs and multiple independent lumen catheter |
US20020156354A1 (en) | 2001-04-20 | 2002-10-24 | Larson Eric Russell | Pulse oximetry sensor with improved spring |
US6679837B2 (en) * | 2001-06-01 | 2004-01-20 | Intlas Ltd. | Laser light irradiation apparatus |
US6801798B2 (en) | 2001-06-20 | 2004-10-05 | Purdue Research Foundation | Body-member-illuminating pressure cuff for use in optical noninvasive measurement of blood parameters |
SG126677A1 (en) | 2001-06-26 | 2006-11-29 | Meng Ting Choon | Method and device for measuring blood sugar level |
US6697658B2 (en) | 2001-07-02 | 2004-02-24 | Masimo Corporation | Low power pulse oximeter |
DE10139379A1 (en) | 2001-08-10 | 2003-03-06 | Siemens Ag | Inductive motion sensor has sensor coils beside permanent magnet field generator |
US6654621B2 (en) | 2001-08-29 | 2003-11-25 | Bci, Inc. | Finger oximeter with finger grip suspension system |
US6668183B2 (en) | 2001-09-11 | 2003-12-23 | Datex-Ohmeda, Inc. | Diode detection circuit |
IL145445A (en) | 2001-09-13 | 2006-12-31 | Conmed Corp | Signal processing method and device for signal-to-noise improvement |
US6723077B2 (en) | 2001-09-28 | 2004-04-20 | Hewlett-Packard Development Company, L.P. | Cutaneous administration system |
US7162306B2 (en) | 2001-11-19 | 2007-01-09 | Medtronic Physio - Control Corp. | Internal medical device communication bus |
JP3709836B2 (en) | 2001-11-20 | 2005-10-26 | コニカミノルタセンシング株式会社 | Blood component measuring device |
US6822564B2 (en) | 2002-01-24 | 2004-11-23 | Masimo Corporation | Parallel measurement alarm processor |
DE60315596T2 (en) | 2002-01-31 | 2008-05-15 | Loughborough University Enterprises Ltd., Loughborough | VENOUS PULSE OXIMETRY |
CA2475726C (en) | 2002-02-14 | 2010-02-09 | Toshinori Kato | Apparatus for evaluating biological function |
WO2003071939A1 (en) | 2002-02-22 | 2003-09-04 | Masimo Corporation | Active pulse spectraphotometry |
US20050177034A1 (en) | 2002-03-01 | 2005-08-11 | Terry Beaumont | Ear canal sensing device |
US6863652B2 (en) | 2002-03-13 | 2005-03-08 | Draeger Medical Systems, Inc. | Power conserving adaptive control system for generating signal in portable medical devices |
DE10213692B4 (en) | 2002-03-27 | 2013-05-23 | Weinmann Diagnostics Gmbh & Co. Kg | Method for controlling a device and device for measuring ingredients in the blood |
US6711426B2 (en) | 2002-04-09 | 2004-03-23 | Spectros Corporation | Spectroscopy illuminator with improved delivery efficiency for high optical density and reduced thermal load |
US6610474B1 (en) * | 2002-04-25 | 2003-08-26 | University Hospitals Of Cleveland | Cells for detection of influenza and parainfluenza viruses |
US6690958B1 (en) | 2002-05-07 | 2004-02-10 | Nostix Llc | Ultrasound-guided near infrared spectrophotometer |
US6711425B1 (en) | 2002-05-28 | 2004-03-23 | Ob Scientific, Inc. | Pulse oximeter with calibration stabilization |
JP4040913B2 (en) | 2002-06-07 | 2008-01-30 | 株式会社パルメディカル | Noninvasive arteriovenous oxygen saturation measuring device |
US6909912B2 (en) | 2002-06-20 | 2005-06-21 | University Of Florida | Non-invasive perfusion monitor and system, specially configured oximeter probes, methods of using same, and covers for probes |
US7024235B2 (en) | 2002-06-20 | 2006-04-04 | University Of Florida Research Foundation, Inc. | Specially configured nasal pulse oximeter/photoplethysmography probes, and combined nasal probe/cannula, selectively with sampler for capnography, and covering sleeves for same |
JP4395068B2 (en) | 2002-07-15 | 2010-01-06 | イタマール メディカル リミテッド | Body surface probe, apparatus, and method for non-invasive detection of medical conditions |
JP2004113353A (en) | 2002-09-25 | 2004-04-15 | Citizen Watch Co Ltd | Blood analyzer |
US7245789B2 (en) | 2002-10-07 | 2007-07-17 | Vascular Imaging Corporation | Systems and methods for minimally-invasive optical-acoustic imaging |
US7366333B2 (en) | 2002-11-11 | 2008-04-29 | Art, Advanced Research Technologies, Inc. | Method and apparatus for selecting regions of interest in optical imaging |
WO2004047631A2 (en) | 2002-11-22 | 2004-06-10 | Masimo Laboratories, Inc. | Blood parameter measurement system |
JP3944448B2 (en) | 2002-12-18 | 2007-07-11 | 浜松ホトニクス株式会社 | Blood measuring device |
JP4284674B2 (en) | 2003-01-31 | 2009-06-24 | 日本光電工業株式会社 | Absorbent concentration measuring device in blood |
WO2004069046A1 (en) | 2003-02-05 | 2004-08-19 | Philips Intellectual Property & Standards Gmbh | Finger medical sensor |
JP2004248819A (en) | 2003-02-19 | 2004-09-09 | Citizen Watch Co Ltd | Blood analyzer |
JP4526532B2 (en) | 2003-02-27 | 2010-08-18 | ネルコア ピューリタン ベネット アイルランド | Signal analysis and processing methods |
JP2004290545A (en) | 2003-03-28 | 2004-10-21 | Citizen Watch Co Ltd | Blood analyzer |
US6947780B2 (en) | 2003-03-31 | 2005-09-20 | Dolphin Medical, Inc. | Auditory alarms for physiological data monitoring |
US20060142808A1 (en) | 2003-04-22 | 2006-06-29 | Christopher Pearce | Defibrillator/monitor system having a pod with leads capable of wirelessly communicating |
KR100571811B1 (en) | 2003-05-09 | 2006-04-17 | 삼성전자주식회사 | Ear type measurement apparatus for bio signal |
CN100440231C (en) | 2003-06-11 | 2008-12-03 | 德尔格医疗系统有限公司 | Portable patient monitoring system including location identification capability |
US7047056B2 (en) | 2003-06-25 | 2006-05-16 | Nellcor Puritan Bennett Incorporated | Hat-based oximeter sensor |
JP4326866B2 (en) | 2003-07-17 | 2009-09-09 | 帝人株式会社 | How to predict the occurrence of acute exacerbations |
JP3915754B2 (en) | 2003-08-04 | 2007-05-16 | ソニー株式会社 | Mobile terminal and ringtone generation method |
US7144268B2 (en) | 2003-08-19 | 2006-12-05 | Spacelabs Medical, Inc. | Latching medical patient parameter safety connector and method |
WO2005020120A2 (en) | 2003-08-20 | 2005-03-03 | Koninklijke Philips Electronics N.V. | A system and method for detecting signal artifacts |
US20050054907A1 (en) | 2003-09-08 | 2005-03-10 | Joseph Page | Highly portable and wearable blood analyte measurement system |
WO2005025399A2 (en) | 2003-09-12 | 2005-03-24 | Or-Nim Medical Ltd. | Noninvasive optical monitoring of region of interest |
US7379769B2 (en) | 2003-09-30 | 2008-05-27 | Sunnybrook Health Sciences Center | Hybrid imaging method to monitor medical device delivery and patient support for use in the method |
US7373193B2 (en) | 2003-11-07 | 2008-05-13 | Masimo Corporation | Pulse oximetry data capture system |
US20050113651A1 (en) | 2003-11-26 | 2005-05-26 | Confirma, Inc. | Apparatus and method for surgical planning and treatment monitoring |
US20050154285A1 (en) | 2004-01-02 | 2005-07-14 | Neason Curtis G. | System and method for receiving and displaying information pertaining to a patient |
US20050154286A1 (en) | 2004-01-02 | 2005-07-14 | Neason Curtis G. | System and method for receiving and displaying information pertaining to a patient |
US7254425B2 (en) * | 2004-01-23 | 2007-08-07 | Abbott Laboratories | Method for detecting artifacts in data |
US20050267346A1 (en) | 2004-01-30 | 2005-12-01 | 3Wave Optics, Llc | Non-invasive blood component measurement system |
CA2555807A1 (en) | 2004-02-12 | 2005-08-25 | Biopeak Corporation | Non-invasive method and apparatus for determining a physiological parameter |
US7277741B2 (en) | 2004-03-09 | 2007-10-02 | Nellcor Puritan Bennett Incorporated | Pulse oximetry motion artifact rejection using near infrared absorption by water |
CN1930572A (en) | 2004-03-15 | 2007-03-14 | 西门子医疗健康服务公司 | A mobile patient care system |
US20050228248A1 (en) | 2004-04-07 | 2005-10-13 | Thomas Dietiker | Clip-type sensor having integrated biasing and cushioning means |
JP2008500846A (en) * | 2004-04-09 | 2008-01-17 | パロマー メディカル テクノロジーズ,インク. | Method and product for making a grid of EMR-treated isolated points in tissue and use thereof |
US7184148B2 (en) | 2004-05-14 | 2007-02-27 | Medeikon Corporation | Low coherence interferometry utilizing phase |
US7327463B2 (en) | 2004-05-14 | 2008-02-05 | Medrikon Corporation | Low coherence interferometry utilizing magnitude |
US7623988B2 (en) * | 2004-06-23 | 2009-11-24 | Cybiocare Inc. | Method and apparatus for the monitoring of clinical states |
US7551950B2 (en) | 2004-06-29 | 2009-06-23 | O2 Medtech, Inc,. | Optical apparatus and method of use for non-invasive tomographic scan of biological tissues |
US7343186B2 (en) | 2004-07-07 | 2008-03-11 | Masimo Laboratories, Inc. | Multi-wavelength physiological monitor |
US20060111622A1 (en) * | 2004-10-07 | 2006-05-25 | Sean Merritt | Apparatus and method for monitoring deep tissue temperature using broadband diffuse optical spectroscopy |
US20060229515A1 (en) * | 2004-11-17 | 2006-10-12 | The Regents Of The University Of California | Fiber optic evaluation of tissue modification |
US7819812B2 (en) | 2004-12-15 | 2010-10-26 | Neuropace, Inc. | Modulation and analysis of cerebral perfusion in epilepsy and other neurological disorders |
US7341562B2 (en) | 2004-12-15 | 2008-03-11 | Neuropace, Inc. | Modulation and analysis of cerebral perfusion in epilepsy and other neurological disorders |
US20060167367A1 (en) | 2004-12-23 | 2006-07-27 | James Stanczak | Method and system for collecting data on a plurality of patients |
US20060178588A1 (en) | 2005-01-03 | 2006-08-10 | Lee Brody | System and method for isolating effects of basal autonomic nervous system activity on heart rate variability |
CN101198277B (en) | 2005-02-22 | 2011-06-15 | 海尔思-斯玛特有限公司 | Systems for physiological and psycho-physiological monitoring |
US20060217602A1 (en) * | 2005-03-04 | 2006-09-28 | Alan Abul-Haj | Method and apparatus for noninvasive targeting |
DK1863387T3 (en) | 2005-03-16 | 2013-09-16 | Or Nim Medical Ltd | NON-INVASIVE MEASUREMENTS IN A HUMAN BODY |
US7548771B2 (en) | 2005-03-31 | 2009-06-16 | Nellcor Puritan Bennett Llc | Pulse oximetry sensor and technique for using the same on a distal region of a patient's digit |
US7400257B2 (en) | 2005-04-06 | 2008-07-15 | Rivas Victor A | Vital signals and glucose monitoring personal wireless system |
KR100716824B1 (en) | 2005-04-28 | 2007-05-09 | 삼성전기주식회사 | Printed circuit board with embedded capacitors using hybrid materials, and manufacturing process thereof |
US20060272418A1 (en) | 2005-06-03 | 2006-12-07 | Brown University | Opto-acoustic methods and apparatus for perfoming high resolution acoustic imaging and other sample probing and modification operations |
US7624640B2 (en) | 2005-06-03 | 2009-12-01 | Brown University | Opto-acoustic methods and apparatus for performing high resolution acoustic imaging and other sample probing and modification operations |
US7393327B2 (en) | 2005-06-29 | 2008-07-01 | Fukuda Denshi Co., Ltd. | Blood pressure monitoring apparatus |
US20070118045A1 (en) | 2005-10-21 | 2007-05-24 | Endothelix, Inc. | Iontophoresis challenge for monitoring cardiovascular status |
EP2407095A1 (en) | 2006-02-22 | 2012-01-18 | DexCom, Inc. | Analyte sensor |
US20100049180A1 (en) * | 2007-10-19 | 2010-02-25 | Lockheed Martin Corporation | System and method for conditioning animal tissue using laser light |
US20080096495A1 (en) | 2006-10-24 | 2008-04-24 | Ein-Yiao Shen | Collaborated Physiological Data Testing Instrument Module in Mobile Communication Device |
US20080208912A1 (en) | 2007-02-26 | 2008-08-28 | Garibaldi Jeffrey M | System and method for providing contextually relevant medical information |
US8690864B2 (en) * | 2007-03-09 | 2014-04-08 | Covidien Lp | System and method for controlling tissue treatment |
US7734321B2 (en) * | 2007-07-13 | 2010-06-08 | All Protect, Llc | Apparatus for non-invasive spectroscopic measurement of analytes, and method of using the same |
DE102008006245A1 (en) * | 2008-01-25 | 2009-07-30 | Nirlus Engineering Ag | Method for the noninvasive, optical determination of the temperature of a medium |
JP3170866U (en) | 2011-07-22 | 2011-10-06 | 和行 久保田 | Variety bag |
-
2009
- 2009-09-29 US US12/569,721 patent/US8376955B2/en active Active
-
2013
- 2013-01-15 US US13/742,107 patent/US20130131671A1/en not_active Abandoned
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4246784A (en) * | 1979-06-01 | 1981-01-27 | Theodore Bowen | Passive remote temperature sensor system |
US20020035341A1 (en) * | 1995-08-09 | 2002-03-21 | Rio Grande Medical Technologies, Inc. | Method and apparatus for non-invasive blood analyte measurement with fluid compartment equilibration |
US20040167382A1 (en) * | 1995-08-09 | 2004-08-26 | Gardner Craig M. | Non-invasive determination of direction and rate of change of an analyte |
US6615071B1 (en) * | 1995-09-20 | 2003-09-02 | Board Of Regents, The University Of Texas System | Method and apparatus for detecting vulnerable atherosclerotic plaque |
US6763261B2 (en) * | 1995-09-20 | 2004-07-13 | Board Of Regents, The University Of Texas System | Method and apparatus for detecting vulnerable atherosclerotic plaque |
US6355030B1 (en) * | 1998-09-25 | 2002-03-12 | Cardiothoracic Systems, Inc. | Instruments and methods employing thermal energy for the repair and replacement of cardiac valves |
US20030236443A1 (en) * | 2002-04-19 | 2003-12-25 | Cespedes Eduardo Ignacio | Methods and apparatus for the identification and stabilization of vulnerable plaque |
US20090143774A1 (en) * | 2006-05-30 | 2009-06-04 | Koninklijke Philips Electronics N.V. | Apparatus for depth-resolved measurements of properties of tissue |
US20100069782A1 (en) * | 2007-06-15 | 2010-03-18 | University Of Tennessee Research Foundation | Passive Microwave Assessment of Human Body Core to Surface Temperature Gradients and Basal Metabolic Rate |
US8013745B2 (en) * | 2007-06-15 | 2011-09-06 | University Of Tennessee Research Foundation | Passive microwave assessment of human body core to surface temperature gradients and basal metabolic rate |
US20090005771A1 (en) * | 2007-06-28 | 2009-01-01 | Chad Allen Lieber | Optical Pyrometric Catheter for Tissue Temperature Monitoring During Cardiac Ablation |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8855153B2 (en) * | 2012-11-08 | 2014-10-07 | Hon Hai Precision Industry Co., Ltd. | Laser machining control system through feedback |
US11648047B2 (en) | 2017-10-06 | 2023-05-16 | Vive Scientific, Llc | System and method to treat obstructive sleep apnea |
DE102019121366A1 (en) * | 2019-08-07 | 2021-02-11 | Aesculap Ag | Apparatus and method for measuring tissue temperature |
Also Published As
Publication number | Publication date |
---|---|
US8376955B2 (en) | 2013-02-19 |
US20110077547A1 (en) | 2011-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6592566B2 (en) | Assessment of tissue or damage depth using time-resolved light scattering spectroscopy | |
JP6766244B2 (en) | Optical lesion assessment | |
JP5607358B2 (en) | Measurement of tissue oxygenation | |
JP5214589B2 (en) | Tissue variation measurement using optical fiber | |
US20130131671A1 (en) | Spectroscopic method and system for assessing tissue temperature | |
US8426819B2 (en) | Method for the non-invasive optic determination of the temperature of a medium | |
JP2007509718A (en) | Devices and methods for monitoring body fluid and electrolyte disorders | |
US10531921B2 (en) | Tissue sealing device with optical feedback | |
JPH07284490A (en) | Glucose concentration measuring apparatus | |
CN105726117B (en) | Spectral sensing of ablation | |
JP5807386B2 (en) | Biological tissue degeneration equipment | |
US10314650B2 (en) | Spectral sensing of ablation | |
US11751938B2 (en) | Ablation catheter with blood perfusion sensor | |
US11490957B2 (en) | Spectral sensing of ablation | |
EP3020345A1 (en) | Tissue sealing device with optical feedback |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: COVIDIEN LP, MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BAKER, CLARK R., JR.;REEL/FRAME:032352/0478 Effective date: 20090929 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |